TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
INKT

Mink Therapeutics Inc

Healthcare · Biotechnology

12.60$ +2.4% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INKT
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
70.2% 78.1% 98.5% 95.0% 79.0% 87.2% 97.3%
22.8% 59.1% 96.6% 91.4% 74.0% 80.0% 93.8%
22.8% 59.1% 96.6% 91.4% 74.0% 80.0% 93.8%
40.2% 5.6% 0.1% – – – –
6.7% 22.6% 0.0% – – – –
29.8% 10.1% 1.5% 5.0% – – –
2,875.9% 1,282.7% 40.9% 101.9% 496.6% 442.4% 199.9%
566.8% 312.2% 40.9% 59.1% 250.5% 121.7% 91.5%
363.5% – – – – – 36.4%
187.6% 69.0% 7.4% 27.1% 85.9% 47.7% 24.1%
2,046.8% 962.1% – – – 86.1% –
-2,775.9% -1,182.7% 59.1% -1.9% -396.6% -342.4% -99.9%
-2,788.3% -1,157.7% -206.1% -516.7% -2,930.3% -2,520.3% -1,100.3%
184.0% 72.6% 8.3% 15.7% 75.5% 67.5% 30.0%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?